sacituzumab
gilead sciences
['trodelvy', 'bcsm', 'breast']
trodelvy significantly improved overall survival for patients with hr-positive/her2 negative #metastaticbreastcancer who are endocrine therapy-resistant, a population with limited treatment options, explained from at #esmo22. #bcsm 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.